India disposable syringes market seen reaching $385.5M by 2030

India’s disposable syringes market is projected to more than double by 2030 as surgical procedures rise, injectable drug use expands and hospitals push safer, single-use devices. Allied Market Research says safety syringes and immunization demand will be key growth drivers over the next decade.

Why it matters: - The India disposable syringes market is tied to infection control, patient safety and the growth of injectable treatments across healthcare settings. - Higher demand for safety syringes can reduce needlestick injuries for healthcare workers. - Stronger adoption of single-use devices also supports safer injection practices as chronic disease treatment and vaccination needs expand.

What happened: - Allied Market Research valued the India disposable syringes market at $148.0 million in 2020. - The market is projected to reach $385.54 million by 2030. - The forecast implies a 10.3% compound annual growth rate from 2021 to 2030. - The report cites rising surgical procedures across India as a major market driver. - The report is titled "India Disposable Syringes Market by Product Type, Application, and End User: Country Opportunity Analysis and Industry Forecast, 2021–2030." - The company offered a sample PDF report. - The company also offered a purchase inquiry page.

The details: - Injectable medications remain essential in healthcare settings where oral drugs have limited bioavailability or effectiveness. - Rising healthcare expenditure is supporting demand. - Chronic diseases including diabetes, cancer and cardiovascular disorders are increasing syringe use. - Growing awareness of infection control is adding to market growth. - Government initiatives promoting safe injection practices are supporting adoption. - Improved healthcare infrastructure is also contributing to expansion. - Safety disposable syringes cost more than conventional alternatives, which can limit adoption in some settings. - Demand for safe, single-use medical devices and wider healthcare access in emerging regions are creating opportunities. - Albert David Ltd., Baxter International India Pvt. Ltd., B. Braun Medical India Pvt. Ltd., Becton, Dickinson India Pvt. Ltd., Cardinal Health India Pvt. Ltd., Hindustan Syringes & Medical Devices Ltd., Nipro Medical Corporation India Pvt. Ltd., Novo Nordisk India Pvt. Ltd., Terumo Corporation India Pvt. Ltd. and Teleflex Medical Pvt. Ltd. are among the leading companies in the market. - Market participants are focusing on product innovation, manufacturing expansion and strategic partnerships. - The safety disposable syringe segment held the largest share in 2020 and is expected to grow fastest through 2030. - The therapeutic injection segment led the market in 2020. - The immunization injection segment is expected to post the highest growth rate. - Hospitals were the largest end-user segment by revenue.

Between the lines: - The forecast points to a market where safety and compliance matter as much as volume. - Faster growth in safety syringes suggests regulation and worker protection are shaping purchasing decisions. - Immunization growth signals that public health programs could become a bigger demand engine alongside chronic care. - The competitive field remains fragmented enough that manufacturers are leaning on scale, new products and partnerships to stand out.

What's next: - The market is expected to grow robustly through 2030 as healthcare spending rises and injectable treatment volumes increase. - Expansion in immunization programs should add demand for disposable syringes. - Ongoing design advances and safety improvements may open new opportunities for suppliers. - The report also covers regional views across North America, Europe, Asia-Pacific and LAMEA.